Literature DB >> 2890817

Antiviral therapy.

M J Wood1, A M Geddes.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2890817     DOI: 10.1016/s0140-6736(87)91329-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients.

Authors:  A M Taburet; C Katlama; C Blanshard; G Zorza; D Gazzard; E Dohin; B G Gazzard; C Frostegard; E Singlas
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 2.  New antiviral and antifungal drugs.

Authors:  P G Davey
Journal:  BMJ       Date:  1990-03-24

Review 3.  Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis.

Authors:  P Chrisp; S P Clissold
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

Review 4.  Antiviral drugs.

Authors:  E H Wiltink; R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

5.  Effects of acyclovir and vidarabin 5'-monophosphate on anti-duck hepatitis B virus in an in vitro culture system.

Authors:  K Motegi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

Review 6.  The future of antiviral chemotherapy.

Authors:  S Crowe; J Mills
Journal:  Dermatol Clin       Date:  1988-10       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.